Related Experiment Video
Updated: Jul 20, 2025
08:58
Optogenetic Manipulation of Neural Circuits During Monitoring Sleep/wakefulness States in Mice
Published on: June 19, 2019
9.8K
GABAergic modulation of sleep-wake states.
Yo Oishi1, Yuki C Saito1, Takeshi Sakurai1
1International Institute for Integrative Sleep Medicine (WPI-IIIS), University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan; Institute of Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan.
Pharmacology & Therapeutics
|August 4, 2023
Summary
GABAergic neurotransmission, crucial for sleep, also promotes wakefulness in specific brain areas. This review highlights GABAergic neurons in the preoptic area and ventral tegmental area for sleep-wake cycle regulation.
Area of Science:
- Neuroscience
- Sleep Medicine
- Neuropharmacology
Background:
- Benzodiazepines enhance GABAA receptor activity, highlighting GABAergic neurotransmission's role in sleep.
- Emerging evidence indicates GABAergic neurotransmission also promotes wakefulness in distinct neuronal circuits.
- The precise central nervous system regions where GABAergic neurons regulate sleep-wake cycles remain incompletely understood.
Purpose of the Study:
- To review the involvement of GABAergic neurons in regulating sleep-wake cycles.
- To focus on the roles of GABAergic neurons in the preoptic area (POA) and ventral tegmental area (VTA).
- To synthesize current research on GABAergic neurotransmission in sleep-wake regulation.
Main Methods:
- Literature review of existing research on GABAergic neurotransmission and sleep-wake cycles.
- Analysis of studies focusing on the preoptic area (POA) and ventral tegmental area (VTA).
- Inclusion of recent findings, including the authors' own research.
Main Results:
- GABAergic neurotransmission is critical for both sleep initiation and maintenance.
- GABAergic neurons in specific circuits, including the POA and VTA, play a vital role in promoting wakefulness.
- Recent research confirms the significance of GABAergic neurotransmission in the POA and VTA for sleep-wake regulation.
Conclusions:
- GABAergic neurotransmission is a key regulator of the sleep-wake cycle.
- Specific GABAergic neuronal populations in the POA and VTA are essential for controlling sleep and wakefulness.
- Further research into these GABAergic circuits can inform therapeutic strategies for sleep disorders.
More Related Videos
Related Concept Videos
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
202
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
202
01:23Sedatives and Hypnotics: Overview
446
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
446
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
461
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
461
01:14CNS Depressants: Barbiturates and Benzodiazepines
322
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
322
01:19Management of Insomnia
281
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
281
01:19Sedatives and Hypnotics Drugs: Benzodiazepines
291
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
291